Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI3K/Akt/NFκB Pathway in Human Non-small Cell Lung Cancer (vol 17, pg 1839, 2011)

被引：1
|
作者：
Song, Libing
Xiong, Huaping
Li, Jun
Liao, Wenting
Wang, Lan
Wu, Jueheng
Li, Mengfeng
机构：
来源：
CLINICAL CANCER RESEARCH | 2022年 / 28卷 / 08期
关键词：
D O I：
10.1158/1078-0432.CCR-22-0506
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1740 / 1740
页数：1
相关论文
共 50 条
  • [21] Polygalacin D induces apoptosis and cell cycle arrest via the PI3K/Akt pathway in non-small cell lung cancer
    Seo, Yun-Soo
    Kang, Ok-Hwa
    Kong, Ryong
    Zhou, Tian
    Kim, Sang-A
    Ryu, ShiYong
    Kim, Hak-Ryul
    Kwon, Dong-Yeul
    ONCOLOGY REPORTS, 2018, 39 (04) : 1702 - 1710
  • [22] SHIP1 inhibits cell growth, migration, and invasion in non-small cell lung cancer through the PI3K/AKT pathway
    Fu, Qiaofen
    Huang, Yuhui
    Ge, Chunlei
    Li, Zhen
    Tian, Hui
    Li, Qiaolin
    Li, Hongshuai
    Li, Ruilei
    Tao, Xingyu
    Xue, Yuanbo
    Wang, Ying
    Yang, Guanqin
    Fang, Weiyi
    Song, Xin
    ONCOLOGY REPORTS, 2019, 41 (04) : 2337 - 2350
  • [23] LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway
    Liu, L.
    Zhou, X-Y
    Zhang, J-Q
    Wang, G-G
    He, J.
    Chen, Y-Y
    Huang, C.
    Li, L.
    Li, S-Q
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (24) : 8722 - 8730
  • [24] Ailanthone Increases Cisplatin-induced Apoptosis and Autophagy in Cisplatin Resistance Non-small Cell Lung Cancer Cells through the PI3K/AKT/mTOR Pathway
    Di, Jinna
    Bo, Wei
    Wang, Chun
    Liu, Chunying
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [25] Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
    Fumarola, Claudia
    Bonelli, Mara A.
    Petronini, Pier Giorgio
    Alfieri, Roberta R.
    BIOCHEMICAL PHARMACOLOGY, 2014, 90 (03) : 197 - 207
  • [26] Thymidylate synthase confers pemetrexed resistance of non-small cell lung cancer cells by EGFR/PI3K/AKT pathway
    Zhang, Dan
    Liu, Haijing
    Yi, Zhennan
    Lu, Yuanyuan
    Chen, Yanyan
    Su, Weiqiang
    Lin, Huibing
    Zhang, Zhihui
    Lei, Wei
    BIOCELL, 2021, 45 (03) : 617 - 625
  • [27] PI3K/AKT inhibition induces compensatory activation of the MET/STAT3 pathway in non-small cell lung cancer
    Bian, Chunan
    Liu, Zonghang
    Li, Dakou
    Zhen, Lifeng
    ONCOLOGY LETTERS, 2018, 15 (06) : 9655 - 9662
  • [28] Ran GTPase Induces EMT and Enhances Invasion in Non-Small Cell Lung Cancer Cells Through Activation of PI3K-AKT Pathway
    Ning, Jinfeng
    Liu, Wei
    Zhang, Jinfeng
    Lang, Yaoguo
    Xu, Shidong
    ONCOLOGY RESEARCH, 2013, 21 (02) : 67 - 72
  • [29] miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR
    Ma, Hui-Ping
    Kong, Wei-Xiang
    Li, Xiu-Ying
    Li, Wei
    Zhang, Yan
    Wu, Yan
    ONCOLOGY REPORTS, 2019, 41 (03) : 1549 - 1559
  • [30] miRNA-103 promotes chondrocyte apoptosis by downregulation of Sphingosine kinase-1 and ameliorates PI3K/AKT pathway in osteoarthritis
    不详
    BIOSCIENCE REPORTS, 2024, 44 (10)
12345